The absolute requirement of CIITA-driven MHC-II positive tumor cells to trigger tumor-specific CD4+ Th cells and initiate the cascade of events, leading to an efficient adaptive anti-tumor immune response raised several key questions. This evidence concerns the gene CD4 and neoplasm.